Cargando…

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Short-term outcomes in kidney transplantation are marred by progressive transplant failure and mortality secondary to immunosuppression toxicity. Immune modulation with autologous polyclonal regulatory T cell (Treg) therapy may facilitate immunosuppression reduction promoting better long-term clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harden, Paul N., Game, David S., Sawitzki, Birgit, Van der Net, Jeroen B., Hester, Joanna, Bushell, Andrew, Issa, Fadi, Brook, Matthew O., Alzhrani, Alaa, Schlickeiser, Stephan, Scotta, Cristiano, Petchey, William, Streitz, Mathias, Blancho, Gilles, Tang, Quizhi, Markmann, James, Lechler, Robert I., Roberts, Ian S. D., Friend, Peter J., Hilton, Rachel, Geissler, Edward K., Wood, Kathryn J., Lombardi, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613119/ https://www.ncbi.nlm.nih.gov/pubmed/33171020 http://dx.doi.org/10.1111/ajt.16395

Ejemplares similares

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
por: Brook, Matthew Oliver, et al.
Publicado: (2022)

A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
por: Fraser, Henrieta, et al.
Publicado: (2018)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
por: Alzhrani, Alaa, et al.
Publicado: (2020)

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
por: Safinia, Niloufar, et al.
Publicado: (2015)

Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
por: Streitz, Mathias, et al.
Publicado: (2013)

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Stark, Helen L., et al.
Publicado: (2021)

Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients
por: Sherston, S N, et al.
Publicado: (2014)

Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021)

Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16(+) Cell Subsets
por: Stobutzki, Nadja, et al.
Publicado: (2019)

Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells
por: Safinia, Niloufar, et al.
Publicado: (2018)

Expanded Regulatory T Cells Induce Alternatively Activated Monocytes With a Reduced Capacity to Expand T Helper-17 Cells
por: Romano, Marco, et al.
Publicado: (2018)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4(+) memory T cells
por: Truong, Kim-Long, et al.
Publicado: (2019)

Batch Effects during Human Bone Marrow Stromal Cell Propagation Prevail Donor Variation and Culture Duration: Impact on Genotype, Phenotype and Function
por: Brachtl, Gabriele, et al.
Publicado: (2022)

Transplantation tolerance
por: Salisbury, Emma M., et al.
Publicado: (2013)

Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma
por: Blum, Agnieszka, et al.
Publicado: (2019)

Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis
por: Albany, Caraugh J., et al.
Publicado: (2019)

CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2017)

Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective
por: ten Brinke, Anja, et al.
Publicado: (2019)

Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment
por: Jacob, Jacinta, et al.
Publicado: (2020)

PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype
por: Fanelli, Giorgia, et al.
Publicado: (2021)

Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
por: Povoleri, Giovanni Antonio Maria, et al.
Publicado: (2013)

IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
por: Kawai, Kento, et al.
Publicado: (2021)

Barriers to Treg therapy in Europe: From production to regulation
por: Hennessy, Conor, et al.
Publicado: (2023)

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort
por: Ten Brinke, Anja, et al.
Publicado: (2015)

Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model
por: Issa, Fadi, et al.
Publicado: (2012)

Regulatory T-cell therapy approaches
por: McCallion, Oliver, et al.
Publicado: (2022)

Comparison of cochlear duct length between the Saudi and non-Saudi populations
por: Alanazi, Alaa, et al.
Publicado: (2018)

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
por: Roemhild, Andy, et al.
Publicado: (2020)

Both Maturation and Survival of Human Dendritic Cells are Impaired in the Presence of Anergic/Suppressor T Cells
por: Frasca, L., et al.
Publicado: (2003)

CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells
por: Stanko, Katarina, et al.
Publicado: (2018)

Recent advances in our understanding of the allograft response
por: Hennessy, Conor, et al.
Publicado: (2021)

Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial
por: Dudreuilh, C, et al.
Publicado: (2023)

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
por: Vanhove, Bernard, et al.
Publicado: (2017)

Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
por: Sagoo, Pervinder, et al.
Publicado: (2012)

Continuous Acquisition of MHC:Peptide Complexes by Recipient Cells Contributes to the Generation of Anti‐Graft CD8(+) T Cell Immunity
por: Smyth, L. A., et al.
Publicado: (2016)

Isolation and freezing of human peripheral blood mononuclear cells from pregnant patients
por: Efthymiou, Athina, et al.
Publicado: (2022)

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Issa, Fadi, et al.
Publicado: (2019)

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine
por: Adigbli, George, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c45lp10gtqo0p1uc99s9cup84o